 |
|
|
| |
Hepatitis C in Patients Without Fibrosis or with Minimal Fibrosis: The Impact of Treatment and Sustained Virologic Response on Patient-Reported Outcomes
|
| |
| |
Reported by Jules Levin
AASLD - American Association for The study of Liver Diseases (AASLD) ⋅ October 20 - 24, 2017 ⋅ Washington DC, USA
Zobair M. Younossi 1, Maria Stepanova 2, Tarik Asselah 3, Graham Foster 4, Keyur Patel 9, Norbert Bräu 5, Mark Swain 10, Tram Tran 11, Rafael Esteban 6, Massimo Colombo 7, Stephen Pianko 12, Linda Henry 2, Marc Bourlière 8
1.Center for Liver Diseases, Inova Fairfax Hospital, Falls Church, VA, United States.
2.Center for Outcomes Research in Liver Disease, Washington DC, United States.
3.Hospital Beaujon, Clichy, France.
4.Queen Mary, University of London, London, United Kingdom.
5.James J. Peters Veterans Affairs Medical Center, New York, NY, United States.
6.Universitat Autonoma de Barcelona, Liver Unit, Bacelona, Spain.
7.Humanitas Clinical and Research Center, Rozzano, Italy.
8.Hospital St. Joseph, Marseille, France.
9.Toronto Center for Liver DIseases, Toronto, ON, Canada.
10. Medicine University of Calgary, Calgary, AB, Canada.
11. Cedars Sinai Medical Center, Los Angeles, CA, United States.
12. Department of Gastroenterology, Monash Medical Centre, Melbourne, VIC, Australia.
|
| |
|
|
|
|
|
